AAPL 192.31 -1.5 (-0.77%)MSFT 107.04 -0.64 (-0.59%)FB 142.18 -0.73 (-0.51%)ZNGA 3.54 -0.02 (-0.70%)NVDA 199.38 -1.21 (-0.60%)WBA 81.94 +0.17 (+0.21%)GOOG 1036.61 -5.93 (-0.57%)PIH 5.6 +0.15 (+2.75%)
AAPL 192.31 -1.5 (-0.77%)MSFT 107.04 -0.64 (-0.59%)FB 142.18 -0.73 (-0.51%)ZNGA 3.54 -0.02 (-0.70%)NVDA 199.38 -1.21 (-0.60%)WBA 81.94 +0.17 (+0.21%)GOOG 1036.61 -5.93 (-0.57%)PIH 5.6 +0.15 (+2.75%)

Financial Summary PTLA Quote Portola Pha

Portola Pharmaceuticals Inc. Quote

Portola Pharmac (PTLA)

20.08 -0.1 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C
Symbol PTLA
Price 20.08
Beta 1.51
Vol Avg 1.64 M
Mkt cap 2.00 B
Shares 60
Last Div Not Available
Div Yield 0.00%
DCF Unlevered -184.95 Strong Sell
DCF Levered -165.40 Strong Sell
ROE -82.30% Strong Sell
ROA -57.89% Strong Sell
Operating Margin -1186.96% Strong Sell
Debt/Equity 64.84% Buy
P/E -4.21 Strong Sell
P/B 3.47 Strong Buy
Company Profile

CEO

William Lis

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.